Related Experiment Video

Updated: May 6, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.3K

Cardiovascular comorbidities in antiphospholipid syndrome

Cezar A Muniz Caldas1, Jozélio Freire de Carvalho

  • 1Internal Medicine Department, Universidade Federal do Pará, Belém-PA, Brazil and Curso de Medicina do Centro Universitário do Estado do Pará - CESUPA, Belém-PA Brazil.

Expert Review of Clinical Immunology
|October 17, 2013
PubMed

Insights

Antiphospholipid syndrome (APS) patients face risks from cardiovascular comorbidities. Understanding these, like metabolic syndrome and vitamin D deficiency, can improve APS patient outcomes and prevent serious events.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Immunology

Background:

  • Antiphospholipid syndrome (APS) is an autoimmune disorder linked to thrombosis and pregnancy loss.
  • Myocardial infarction and stroke are significant causes of mortality in APS patients.
  • Cardiovascular comorbidities can exacerbate APS progression.

Purpose of the Study:

  • To review the literature on cardiovascular comorbidities in antiphospholipid syndrome.
  • To explore the impact of traditional atherosclerosis risk factors, metabolic syndrome, and vitamin D deficiency on APS prognosis.

Main Methods:

  • Literature review of cardiovascular comorbidities in antiphospholipid syndrome.
  • Analysis of how traditional risk factors, metabolic syndrome, and vitamin D deficiency influence APS prognosis.

Main Results:

  • Cardiovascular comorbidities, including atherosclerosis risk factors, metabolic syndrome, and vitamin D deficiency, are prevalent in APS.
  • These comorbidities significantly impact the prognosis and clinical outcomes of patients with antiphospholipid syndrome.

Conclusions:

  • Identifying and managing cardiovascular comorbidities is crucial for improving the prognosis of antiphospholipid syndrome patients.
  • Further research is needed to elucidate the complex interplay between APS and cardiovascular health.

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.7K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.7K

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
773
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
663
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
58
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
659